Dr. Bodor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-2500Fax+1 215-728-3639
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
University of MarylandResidency, Internal Medicine, 2014 - 2017
Louisiana State University School of Medicine in New OrleansClass of 2014
Certifications & Licensure
PA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsReal-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.J Nicholas Bodor, Jessica R Bauman, Elizabeth A Handorf, Eric A Ross, Margie L Clapper
Journal of Cancer Research and Clinical Oncology. 2023-05-01 - 8 citationsMolecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.Robert Hsu, Yasmine Baca, Joanne Xiu, Rongfu Wang, J Nicholas Bodor
Oncotarget. 2021-12-07 - 2 citationsEstimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung CancerChristopher D’Avella, J. Nicholas Bodor
JAMA Network Open. 2021-11-01
Grant Support
- Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung CancerRESEARCH INST OF FOX CHASE CAN CTR2024–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
